The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Jul. 30, 2019
Applicant:

Ludwig Institute for Cancer Research Ltd., Zurich, CH;

Inventors:

Benoit J. Van Den Eynde, Oxford, GB;

Carol S. Leung, Oxford, GB;

Adrian V. S. Hill, Oxford, GB;

Irina Redchenko, Oxford, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/863 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 39/00118 (2018.08); A61K 39/001186 (2018.08); A61K 39/001188 (2018.08); A61P 35/00 (2018.01); C07K 14/70539 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); A61K 2039/545 (2013.01); A61K 2039/585 (2013.01); C07K 2319/02 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/24043 (2013.01);
Abstract

Chimpanzee adenovirus (ChAd) and MVA virus vectors containing polynucleotide sequences encoding cancer antigens are administered sequentially to a subject in a suitable adjuvant in order to achieve a prime boost effect. The polynucleotides are expressed in situ following administration to provide a MAGEA3/linker/NY-ESO-1 fusion protein and variants thereof. Also, a hli/MAGEA3/linker/NY-ESO-1 fusion protein and variants thereof. An improved T cell response is found. In a particular synergistic therapeutic approach a triple combination of ChAdOx and MVA vectors together with chemotherapeutic agent and checkpoint inhibitor results in depleted myeloid derived suppressor cells (MDSC) and dramatically improves survival time in a mouse model of cancer.


Find Patent Forward Citations

Loading…